We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Genedrive Plc | LSE:GDR | London | Ordinary Share | GB00B1VKB244 | ORD 1.5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.173 | -8.66% | 1.825 | 1.80 | 1.85 | 1.85 | 1.825 | 1.83 | 4,023,890 | 14:54:47 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Coml Physical, Biologcl Resh | 55k | -5.15M | -0.0447 | -0.41 | 2.1M |
Date | Subject | Author | Discuss |
---|---|---|---|
16/2/2021 21:20 | GDR got nothing to offer that ncyt and avct can offer. Just been a nightmare for holders. People made money in covid stocks bit if you been in gdr buying above 200p last May , you made jack. | oilisgold | |
16/2/2021 21:19 | I am.with you man!! Just killing people this stock is many false hopes | rayj1 | |
16/2/2021 21:18 | Gdr was always a stock that got pumped. At least a south african approval. No other approvals. | oilisgold | |
16/2/2021 21:14 | Exactly 19th! | hazl | |
16/2/2021 20:36 | Apparently according to some, you need an RNS confirming ‘commercial introduction’ in mid February, in Mid February, because one at the end of January isn’t enough. | 19th hole | |
16/2/2021 19:55 | Your a bellend, a tremendously waste of oxygen. | milliecusto | |
16/2/2021 19:32 | 39 pence .... because i bought some | amaretto1 | |
16/2/2021 19:23 | what is late ? | mrshaungcm | |
16/2/2021 19:23 | Well look at that beautiful 'bowl'! The share has done well this month; from 50p to 130-150 in less than a month. Sure it is going to lose a bit of momentum but the commercial days of this company seem to be upon us so we will see if we get confirmation of that subsequently. I tend to ignore those that seek to gain from causing fear. | hazl | |
16/2/2021 18:16 | "The Companies are planning commercial introduction of the Genedrive kit from mid February, following commercial and technical training of the Beckman sale and support organisations." From Mid FEB, his words . Its 16th FEB today, 2 days late. | oilisgold | |
16/2/2021 18:14 | Why did the CEO say mid FEB? | oilisgold | |
16/2/2021 18:13 | I am creating a small investor action group, i think we need to take legal action . This is not right. | oilisgold | |
16/2/2021 18:12 | Its pass mid FEB, we are 2 days late and no sign. This sadly was again done for all tbe ii to sell out. | oilisgold | |
16/2/2021 18:11 | Its because it freaking spiked that day to 300p and then we got the placing RNS after 9am. Many got spiked that day and still over 50% down. Only ones to benefit are ii. Pathetic . The CEO should be locked up , why did he again say mid FEB? Knowing well the Lambs will buy | oilisgold | |
16/2/2021 17:51 | when was this ever £3.00? you keep harking on the £3.00! last year i managed to sell for £2.20 twice in 24hrs, i can't remember seeing any £3.00! | abbynat | |
16/2/2021 17:34 | Oh dear. Not looking good is it?. Many got spiked at 300p and now at 160p. Lock the rampers up in prison and give them.life sentence | oilisgold | |
16/2/2021 17:05 | B I think the time it takes. | jackdaw4243 | |
16/2/2021 16:42 | Can anyone here give some balance as to the differance between PCR and Laterial flow tests. also the differance in cost to the consumer. Just asking. (:-) | beercapafn | |
16/2/2021 16:38 | thehitman, have you had surgery ? You are making sense recently and I haven't been riled by your posts. What's going on ? | hooded claw | |
16/2/2021 16:26 | GDR... Been consolidating over the last 2-3 trading days now. MM's stocking up as they hold the share price between 130p - 140p range. Flushing out weak sellers as they continue to accumulate as many shares as possible. Shares in issue very limited hence the huge movements in both directions. Anticipated news will see GDR push through 200 - 250p before pushing back up to 300p plus. Hence why the MM's need shares now. Even if we get just £1 per test, GDR will only need to produce 80M kits to equal its market Cap. But the world requires tens of millions if not Billions of these tests. A M/C of £300m plus is conservative. What would be a huge game changer here is a buy out by one a major pharmaceutical companies. These tests are going to be here for a few years there fore guarantee revenue will continue to push the share price north. ADYOR | sep800 | |
16/2/2021 15:58 | Topped up at 131. Just waiting for commerciality news from BC this month.Ignore the noise and as for the value destroyers just put them on filter.It makes life sooo peaceful as they know nothing add nothing | billthebank |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions